Clinical Trial Update: Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating Epigallocatechine Cutaneous for lamellar ichthyosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lamellar Ichthyosis

Drugs mentioned

• Epigallocatechine Cutaneous

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Lamellar Ichthyosis | Phase 3 | Status: UNKNOWN